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1. ABSTRACT
Interleukin-17 (IL-17)-producing T helper cells 
(Th17 cells) constitute a lineage of CD4 effector T 
helper cells that is distinct from the Th1 and Th2 CD4 
phenotypes. In humans, Th17 differentiation is induced 
in the presence of the cytokines IL-1 beta, IL-6 and TGF 
beta, whereas IL-23 maintains Th17 survival. Effector 
human Th17 cells express several cytokines and cell 
surface markers, including IL-17A, IL-17F, IL-22, IL-26, 
CCR6 and TNFα. Studies on human cells have revealed 
that the RORC2 transcription factor plays an effective 
role in Th17 differentiation. Th17 cells contribute to the 
host immune response by involving various pathologies, 
including rheumatoid arthritis, multiple sclerosis and 
Crohn’s disease. However, the full extent of their 
contribution to diseases is being investigated. The 
differentiation of Th17 cells is controlled by many 
transcription factors, including ROR gammat, IRF4, 
RUNX1, BATF, and STAT3. This review covers the 
general principles of CD4 T helper differentiation and the 
known transcription factors that play a role in the recently 
discovered Th17 cells.
2. INTRODUCTION
CD4 T cells are accepted as important actors in 
immune responses due to their capacity to regulate and 
coordinate other cells of the immune system. Because 
they are major players in the immune response, the 
characterization of these cells is crucial. Upon antigenic 
stimulation, naive CD4 T cells activate, proliferate and 
differentiate into different effector helper T cell subsets 
referred to as T helper (Th) 1 and Th2 (1,2). These T 
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cell subsets are characterized by their distinct cytokine 
production profiles and effector functions and carry their 
own specific, distinctive and heritable markers.
Interferon-gamma is the signature cytokine 
produced by Th1 cells and is responsible for immunity 
against intracellular pathogens. In addition, Th1 cells 
express genes associated with cytotoxicity, such as the 
Fas ligand and granzymes. Uncontrolled Th1 responses 
against self-antigens can lead to the development 
of autoimmunity. Th1 cells are generated from naïve 
T helper cells by T cell receptor (TCR) engagement 
and Signal Transducer and Activator of Transcription 
1 (STAT1) signaling, which are induced by the IFN-
induced activation of the IFNgR. Phosphorylated STAT1 
induces the expression of transcription factor T-bet, 
which drives Th1 differentiation by trans-activating the 
Th1 signature cytokine IFN-gamma and the specific 
subunit of the receptor for interleukin (IL)-12, IL-12Rβ2. 
Thus, the cell becomes responsive to IL-12, which 
is produced by activated antigen-presenting cells 
(APCs), and subsequent IL-12 signaling through Signal 
Transducer and Activator of Transcription 4 (STAT4) 
further stabilizes the Th1 phenotype. IL-4, IL-5 and IL-13 
are secreted by Th2 cells, which play important roles in 
clearing extracellular pathogens and mediating allergic 
responses (3-7).
A distinct subset of CD4 T cell effectors 
was recently identified and named T helper 17 cells 
(Th17) because these cells produce the cytokine IL-17 
(Harrington et al., 2005, Park et al., 2005). Th17 cells 
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by the coordinated activity of a series of positive and 
negative regulators (8-10).
3. LINEAGE SPECIFICATION OF TH17 CELLS
3.1. The retinoic acid-related orphan receptors 
(RORs)
ROR is a nuclear receptor containing an 
N-terminal domain, a DNA-binding domain, a hinge 
region, a ligand-binding domain and a C-terminal region. 
In most nuclear receptors, ligand binding to the ligand-
binding domain induces a conformational change, recruits 
transcriptional co-activators and starts the transcription 
process. The ROR family has three members: RORα, 
RORβ and RORg (or RORC). Two different forms of 
RORg, RORg and RORgt (or RORC2), are present in 
mammalian cells, and the only difference between there 
isoforms is the N terminus. RORgt is sufficient for IL-17 
expression as well as Th17 cell differentiation from 
human CD4 T cells. RORgt functions with IL6/STAT3, 
TGFβ, IL-1β and IL-23 to generate Th17 cells. IL-23 
and RORgt provide Th17 mediated immunity. Several 
transcription factors, such as IRF4, BATF, STAT3 and 
E3 deubiquitinase USP17, control Th17 differentiation by 
positively regulating RORC expression (11-15).
Foxo1 inhibits RORgt activity through the T cell 
intrinsic binding of its DNA binding domain, whereas 
inverse agonists and antagonists (such as TMP778) 
of RORgt, as well as siRNAs specific to Rorc, have 
further helped characterize the role of RORgt in Th17 
differentiation (16-19).
In addition to the ROR family of receptors, 
Th17 cells express several other receptors for the 
differentiation or recognition of other immune cells as well 
as target tissues. Of these receptors, the following are 
considered crucial: IL-6R, IL-23R and the TNF receptor 
CD120a, which are responsible for the initial differentiation 
mechanisms of Th17 cells, as well as IL-22R, which 
uses the IL-22 produced by the differentiated cell as its 
ligand and plays a role in the maintenance of the Th17 
phenotype (20-22).
3.2. Interferon-inducible factor-4 (IRF4)
Mammalian interferon regulatory factor (IRF) 
members play many roles in the immune system, 
including the regulation of T cell differentiation. IRF4 
binds weakly to DNA, and its expression is restricted 
to immune cells. IRF4 needs cofactors to stably bind 
DNA. In B cells, the binding of PU.1 to DNA facilitates 
the recruitment of IRF4. In IL-21 treated B cells, IRF4 
interacts with STAT3. Irf4−/− CD4-positive T cells exhibit 
a failure in STAT3 binding and form defective T follicular 
helper cells (Tfh). IRF4 can interact with Batf (the ATL-like 
basic leucine zipper transcription factor)-Jun complex to 
control transcriptional regulation (23-26).
Figure 1. Th17 differentiation. Different members of the ROR family play 
differing roles in various cellular niches. RORC2 is one of the cytokines 
required for Th17 differentiation from naive T cells. RORC2 partners with 
various proteins to affect Th17 differentiation and is positively regulated 
by a number of factors. IRF4, BATF and STAT3 positively regulate 
RORC2, which partners with IL-6, STAT3, IL-1b, IL-23 and TGFb to form 
the interleukin 17 producing Th17 cells.
 
Figure 2. Networking of transcription factors involved in the Th17 
differentiation. Most factors regulate differentiation through collaboration 
(indicated by double-headed arrow), while some regulate the expression 
or activity of others either positively (unilateral arrow) or negatively (blunt-
headed line). Production of IL-17 is the main trait of Th17 cells, which 
is mainly upregulated by RORC2 and BATF. FOXP3 is known to inhibit 
RORC2 and RUNX1, while the remaining proteins either collaborate with 
each other or positively regulate others to drive IL-17 production in Th17 
cells.
also produce the cytokines IL-17A, IL- 17F and IL-22 
(Annunziato et al., 2007, Wilson et al., 2007) and the 
chemokine receptor CCR6 (Acosta-Rodriguez et al., 
2007b, Annunziato et al., 2007, Hirota et al., 2007, Lim 
et al., 2008, Singh et al., 2008). Th17 differentiation 
is directed by lineage-specific transcription factors, 
including RORgt (or RORC) and RORα, and is controlled 
Genes in Th17 differentiation
 429 © 1996-2016
IRF4 aids Th17 cell differentiation and is required 
for the induction of RORgt and RORα. RhoA-associated 
kinase (ROCK) 2 is activated under Th17 polarizing 
conditions and phosphorylates IRF4, which directly 
binds to IL-17A and IL-21 promoters, inducing their 
transcriptional activation. The gene expression of IRF4 
is induced by IL-1beta, which prompts a 5.4-fold increase 
in expression, and by IL-6, which results in a 5.5-fold 
increase in expression. There is a positive relationship 
between IRF4 and IL-17A gene expression, indicating 
that IRF4 plays an important role in human Th17 cell 
differentiation [2-6-7]. IL-6 mainly activates STAT3 through 
the JAK-STAT pathway. STAT3 binds to the promoters of 
various genes, such as RORC, IL-17, IL-17F and IL-21, 
and interacts with the BATF, IRF4 and c-MAF genes. 
These transcriptional factors are important for Th17 cell 
differentiation (23-26).
3.3. B-cell activating transcription factor 
(BATF)
BATF is a basic leucine zipper transcription 
factor of the activator protein-1 (AP-1) family that helps 
generate Th17 cells. BATF is required for the generation 
of T follicular helper (Tfh) cells but not Th1 cells and Treg 
cells. BATF interacts with IRF4 for the generation of Th2 
and Th17 cells and is involved in the induction of the 
IL-10, IL-17alpha and IL-21 genes in T cells. As a result, 
IL-6 activates the function of the BATF/IRF4 complex. 
Previous research has shown that IRF4 is activated 
upon IL-1 signaling and is critical for early Th17 cell 
differentiation. IRF4 interacts with NFATp (nuclear factor 
of activated T-cells) to induce IL-4 expression, suggesting 
that IRF4 modulates NFATp-dependent IL-2 expression, 
which is related with IL-17 production (27-30).
During the process of Th17 differentiation, 
BATF and RORgt directly attach to the promoter of the 
IL17 gene and induce its transcription in a synergistic 
manner. However, it has been observed that Th cells 
lacking BATF fail to differentiate to Th17 cells, despite the 
presence of RORgt, RORα and IL-6. In addition to these 
findings, the function of BATF in Th17 differentiation 
remains unclear (27-30).
3.4. Runt-related transcription factor 1(RUNX1)
Runt-related transcription factor 1 (RUNX1), 
which is also known as acute myeloid leukemia 
1 protein (AML1) and core binding factor subunit 
alpha-2 (CBFA2), is a protein encoded by the RUNX1 gene 
in humans. Transforming growth factor-beta (TGFβ) 
induces the expression of the Runx related transcription 
factors RUNX1 and RUNX3 in CD4-positive T cells. 
This induction is required for the binding of RUNX1 and 
RUNX3 to RUNX binding sites in the FOXP3 promoter. 
Runx proteins form transcriptional complexes with Foxp3, 
RORgt and T bet (inhibitor of RORg gene expression) 
to carry out Th differentiation and cytokine production. 
Runx1 induces RORgt expression and is required for 
the differentiation of Th17 cells and for Foxp3 function. 
The binding of RORgt and Runx1 together to the IL-17α 
locus leads to increased expression of IL-17. The Runx1 
and Runx3 transcription factors induce the differentiation 
of both Th1 and Th17 cells depending on the Runx 
interacting partner (Th1 and Th17 cell transcription 
factors, respectively). However, Foxp3 prevents 
both Runx1 and RORgt activity. Runx1 can modify 
RORgt/Foxp3 complexes and differentially associates 
with RORgt or Foxp3, thus regulating or repressing 
transcriptional activity depending on the specific cytokine 
interactions (31-34).
Both Runx1 and Runx3 maintain high levels 
of Rorc expression in Th17 cells. The Runx transcription 
factors are weak transcriptional factors that interact with other 
transcription factors to activate or repress gene expression. 
If  the concentration of Runx1 is sufficiently high to form 
both the Runx1-T-bet and Runx1-RORgt transcription 
complexes, a T helper cell can simultaneously express 
IFNg and IL-17A. The overexpression of Runx1 or Runx3 
in Th17 cells results in the induction of Stat4 and Tbx21, 
which are downstream factors of IL12 signaling. Runx1 
is a stronger activator of the Tbx21 and Stat4 genes than 
Runx3, resulting in higher amounts of IFNg producing cells. 
Both Runx1 and Runx3 maintain high Rorc expression 
Figure 3. Differentiated interleukin-17 producing T helper (Th17) cells fill 
important niches in the immune system. The key cytokines produced by 
Th17 cells are interleukin (IL) 17A, IL-17F, IL-22 and CCR6.
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despite increased expression of Tbx21 and Stat4 (inhibitors 
of the Rorc gene) (31-34).
3.5. FOXP3 and T-BET
Th17 and Treg cells exhibit a close, 
reciprocal relationship through the molecules TGFβ 
and FOXP3 (forkhead box P3). TGFβ induces Treg 
differentiation and collaborates with or regulates proteins 
in the Th17 differentiation pathway, whereas the Foxp3 
produced by Treg cells antagonizes the RORgt and RORα 
produced by Th17 cells. In addition, retinoic acid causes 
the preferential differentiation of Treg over Th17 cells 
because it enhances TGFβ and inhibits IL-6 receptor 
expression. Furthermore, the transcription factor hypoxia 
inducible factor 1-alpha (HIF1alpha) enhances RORgt 
expression and inhibits Foxp3 expression, which leads 
to the preferential differentiation of Th17 cells compared 
with Treg cells. These findings show that the immune 
system has mechanisms that can induce suppression 
or inflammation as desired, but the implications of this 
conclusion are not known yet (35-39).
Th1 specific T box transcription factor 
(T-bet) exerts an indirect antagonistic effect on Th17 
differentiation by blocking Runx1 from binding and 
activating the RORC gene, which encodes the RORgt 
protein required to activate IL-17. Runx1 and T-bet 
interact during the early Th17 cell differentiation process. 
However, this interaction mutually prevents both proteins 
from activating their target genes, resulting in an equal 
amount of each protein completely inhibiting the other’s 
function in the differentiation process. A higher amount of 
Treg favors Th1 differentiation, whereas a lower amount 
favors Th17 differentiation. T-bet can also bind to a protein 
binding element in the RORC promoter, preventing 
Runx1 from binding to its own adjacent binding site. It 
is unknown whether similar adjacent binding sites exist 
in other Runx1-activated genes, indicating that further 
investigation is required to understand the details and 
specificity of the repression mechanism (40-42).
3.6. Signal transducer and activator of 
transcriptions (STATs)
Signal transducer and activator of transcription 
3 (STAT3) is a transcription factor that is activated by the 
cytokines IL-17, IL-23, IL-6 and IL-21. The importance 
of STAT3 has been shown by the finding that the 
Table 1. Genes and interactions in Th17 function and differentiation
Gene name Role in Th17 Role in immune system Associations with other proteins References
BATF Induces IL-17 transcription 27,30
CCR6 Surface expression factor Associated with colorectal 
cancer and Crohn’s disease
Chemokine receptor 8,9,10
Foxo1 Inhibits the RORC program 16
Foxp3 Antagonizes ROR production by Th17 39
IL-17A Defining gene of Th17 Recruits monocytes and 
neutrophils to inflammation site
Induced by IL-22 8,9,10
IL-17F Pro-inflammatory role in asthma IL-17RA and IL-17RC as receptors 8,9,10
IL-1beta Induces expression of IRF4 24
IL-22 Adaptive innate immune 
response
IL-22R1 and IL-10R2 complex as receptor 9
IL-23 Cytokine expression 14 
IL-26 Induces rapid phosphorylation of STAT3 39 
IL-6 Cytokine expression Activates STAT3 14 
TGFbeta Reciprocal relationship between TGFbeta and Foxp3 5,6,7,8,39
IRF4 Induces RORgammat, RORalpha, IL-17A, IL-22 23,24
RORγt Master regulator transcription 
factor
11,13
RUNX1 Binds to RORgammat, Foxp3 and T-bet 31,32,33
STAT3 STAT regulator of Th17 cells Controls transcription of Th17 differentiation 44,45,46,47
TNFα Th17 cytokine Involved in systemic 
inflammation
46
USP17 Positively regulates RORC expression 15
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deletion of STAT3 in T cells leads to the prevention of 
Th17 differentiation. STAT3 directly binds the IL-17 
promoter, as was shown by a ChIP assay. STAT3 binds to 
enhancers and promoters of genes that are responsible 
for Th17 specification. STAT3 binds not only to the IL-17 
promoter but also to the IL-21, IL-21r and IL-23r genes. 
The important role of STAT3 is the control of transcription 
factors involved in Th17 differentiation, such as IRF4, 
RORgt and Batf. STAT3 also plays an interesting role 
involving Th17 proliferation and survival. It was recently 
shown that the phosphorylation status of Smad2/Smad3 
allows them to act as opposite cofactors of STAT3, which 
regulates Th17 differentiation through RORgt (43-47).
STAT proteins affect Th17 differentiation in 
a positive manner but can also affect this process in a 
negative manner. STAT1, which is activated by IL-23, 
plays an important role in Th17 differentiation. Th17 
differentiation is inhibited in the absence of STAT1 (48). 
Another negative regulator of Th17 differentiation is 
STAT4, which is activated by IL-12 and acts as a positive 
regulator of Th1 differentiation and INFg production. The 
production of IL-17 is suppressed by IL-2 and IFNg (49). 
IL 2 activated STAT5 is involved in Treg and Th17 
differentiation (50).
4. SUMMARY AND PERSPECTIVE
A distinct subset of CD4 T cell effectors 
denoted T helper 17 cells was recently identified. 
Th17 cells contribute to the host immune response 
by involving various pathologies, including multiple 
sclerosis, Crohn’s disease and rheumatoid arthritis. The 
differentiation factors of Th17 cells in humans remain 
under investigation. An increasing body of evidence 
in the literature emphasizes that human CD4 T cells 
have a huge capacity to display plasticity during the 
differentiation of the T helper phenotype. Th17 cells can 
differentiate into Th1 and Th2 phenotypes, whereas 
FoxP3-positive Tregs can differentiate into Th1, Th2 and 
Th17 cells. Therefore, it is important to fully understand 
the differentiation mechanisms of T helper cells.
T helper 17 cells can express more than 
one master transcription factor. The interactions of 
transcription factors with other transcription factors and/or 
regulatory factors need to be further studied in detail. For 
example, BATF transcription factor expression is not 
limited to Th17 cells; in fact, this transcription factor can 
be expressed by all T helper cells, even though its role 
in other Th cells remains unclear. In addition to RORs, 
IRF4 and RUNX1, peroxisome proliferator activated 
receptor gamma (PPARg) (51) and epidermal fatty acid 
binding protein (E-FABP) (52) have been shown to play 
a role in IL17 gene expression. However, the molecular 
mechanism underlying these regulations is not fully 
understood. Furthermore, it is also important to obtain a 
more in-depth understanding of the epigenetic regulation 
of T helper cells in order to comprehend the plasticity and 
stability of T helper cells.
Although the transcription factor RORC2 has 
been shown to be expressed in human Th17 cells, the 
relationships of RORC with other transcription factors 
remain unclear. It has been proposed that microRNAs 
in addition to cytokines and transcription factors can 
also play a role in T helper differentiation. Therefore, 
the roles of microRNAs in Th17 differentiation need to 
be clearly elucidated. MicroRNAs (miRNAs) are 17- to 
23-nt RNA molecules that regulate the expression of 
protein-coding genes. It is very likely that induced or 
suppressed miRNAs regulate key transcription factors 
and other genes involved in T helper cell differentiation. 
Understanding the molecular mechanisms underlying 
Th17 cell differentiation and the regulation of this process 
will help scientists develop better therapeutic approaches 
for the treatment of Th17 cell-driven pathologies.
5. ACKNOWLEDGEMENTS
Research in the Dr. Nalbant’s laboratory is 
supported by grants from the Scientific and Technological 
Research Council of Turkey (TUBITAK; Project# 110T412 
and 113Z362 to Dr. Ayten Nalbant). The funders had no 
role in the study design, data collection and analysis, 
decision to publish, or preparation of the manuscript. The 
authors do not have any type of conflict of interest that 
would affect the compilation of the current knowledge in 
this area for writing this review.
6. REFERENCES
1. TR Mosmann, H Cherwinski, MW Bond, MA 
Giedlin, RL Coffman: Two types of murine 
helper T cell clone. I. Definition according to 
profiles of lymphokine activities and secreted 
proteins. J Immunol 136(7), 2348-2357 (1986)
PMid:2419430
2. AK Abbas, KM Murphy, A Sher: Functional 
diversity of helper T lymphocytes. Nature 383, 
787-793 (1996)
DOI: 10.1038/383787a0
PMid:8893001
3. S Constant, K Bottomly: Induction of TH1 and 
Th2 CD4 T cell responses: the alternative 
approaches. Annu Rev Immunol 15, 
297-322 (1997)
DOI: 10.1146/annurev.immunol.15.1.297
PMid:9143690
4. IC Ho, D Lo, LH Glimcher: c-maf promotes T 
helper cell type 2 (Th2) and attenuates Th1 
differentiation by both interleukin 4- dependent 
and -independent mechanisms. J Exp Med 
Genes in Th17 differentiation
 432 © 1996-2016
188, 1859-1866 (1998)
DOI: 10.1084/jem.188.10.1859
PMid:9815263, PMCid: PMC2212398
5. L Gorelik, PE Fields, RA Flavell: Cutting edge: 
TGF-beta inhibits Th type 2 development 
through inhibition of GATA-3 expression. 
J Immunol 165, 4773-4777 (2000)
DOI: 10.4049/jimmunol.165.9.4773
PMid:11045997
6. L Gorelik, S Constant, RA Flavell. Mechanism 
of transforming growth factor beta-induced 
inhibition of T helper type 1 differentiation. 
J Exp Med 195, 1499-1505 (2002)
DOI: 10.1084/jem.20012076 PMid:12045248 
PMCid: PMC2193549
7. W Chen, W Jin, N Hardegen, KJ Lei, L Li, N 
Marinos, G McGrady, SM Wahl: Conversion 
of peripheral CD4+CD25- naive T cells to 
CD4+ CD25+ regulatory T cells by TGF-beta 
induction of transcription factor Foxp3. J Exp 
Med 198, 1875-1886 (2003)
DOI: 10.1084/jem.20030152
PMid:14676299, PMCid: PMC2194145
8. E Betteli, Y Carrier, W Gao, T Korn, TB Strom, 
M Oukka, HL Weiner, VK Kuchroo: Reciprocal 
developmental pathways for the generation 
of pathogenic effector TH17 and regulatory T 
cells. Nature 441, 235-238 (2006)
DOI: 10.1038/nature04753 
PMid:16648838
9. EV Acosta-Rodriguez, G Napolitani, A 
Lanzavecchia, F Sallusto: Interleukins 1beta 
and 6 but not transforming growth factor-
beta are essential for the differentiation of 
interleukin 17-producing human T helper 
cells. Nat Immunol 8, 942-949 (2007)
DOI: 10.1038/ni1496
PMid:17676045
10. E Betteli, T Korn, VK Kuchroo: Th17: the third 
member of the effector T cell trilogy. Curr Opin 
Immunol 19, 652-657 (2007)
DOI: 10.1016/j.coi.2007.07.020
PMid:1776609, PMCid: PMC2288775
11. II Ivanov, BS McKenie, L Zhou, CE Tadokoro, 
A Lepelley, JJ Lafaille, DJ Cua, DR Littman: 
The orphan nuclear receptor RORgammat 
directs the differentiation program of 
proinflammatory IL-17+ T helper cells. Cell 
126, 1121-1133 (2006).
DOI: 10.1016/j.cell.2006.07.035
PMid:16990136
12. AN Mathur, HC Chang, DG Zisoulis, GL 
Stritesky, Q Yu, JT O’Malley, R Kapur, DE 
Levy, GS Kansas, MH Kaplan: Stat3 and 
Stat4 direct development of IL-17- secreting 
Th cells. J Immunol 178, 4901-4907 (2007).
DOI: 10.4049/jimmunol.178.8.4901
PMid:17404271
13. XO Yang, BP Pappu, R Nurieva, A Akimzhanov, 
HS Kang, Y Chung, L Ma, B Shah, AD 
Panopoulos, KS Schluns, SS Watowich, Q 
Tian, AM Jetten, C Dong: T helper 17 lineage 
differentiation is programmed by orphan 
nuclear receptors ROR alpha and ROR 
gamma. Immunity 28, 29-39 (2008)
DOI: 10.1016/j.immuni.2007.11.016
PMid:18164222, PMCid: PMC2587175
14. L Zhou, II Ivanov, R Spolski, R Min, K 
Shenderov, T Egawa, DE Levy, WJ Leonard, 
DR Littman: IL-6 programs T(H)-17 cell 
differentiation by promoting sequential 
engagement of the IL-21 and IL-23 pathways. 
Nat Immunol 8, 967-974 (2007)
DOI: 10.1038/ni1488 
PMid:17581537
15. L Han, J Yang, X Wang, Q Wu, S Yin, Z Li, J 
Zhang, Y Xing, Z Chen, A Tsun, D Li, M Piccioni, 
Y Zhang, Q Guo, L Jiang, L Bao, L Lv, B Li: 
The E3 deubiquitinase USP17 is a positive 
regulator of retinoic acid-related orphan 
nuclear receptor gt (RORgt) in Th17 cells. 
J Biol Chem 289(37), 25546-25555 (2014)
DOI: 10.1074/jbc.M114.565291
PMid:25070893, PMCid: PMC4162160
16. A Lainé, B Martin, M Luka, L Mir, C Auffray, B 
Lucas, G Bismuth, C Charvet: Foxo1 Is a T Cell-
Intrinsic Inhibitor of the RORgt-Th17 Program. 
J Immunol 195(4), 1791-1803 (2015)
DOI: 10.4049/jimmunol.1500849
PMid:26170390
17. J Skepner, M Trocha, R Ramesh, XA Qu, 
D Schmidt, E Baloglu, M Lobera, S Davis, 
MA Nolan, TJ Carlson, J Hill, S Ghosh, MS 
Sundrud, J Yang: In vivo regulation of gene 
expression and T helper type 17 differentiation 
by RORgt inverse agonists. Immunology 
145(3), 347-256 (2015)
DOI: 10.1111/imm.12444 
PMid:25604624
18. S Xiao, N Yosef, J Yang, Y Wang, L Zhou, C 
Zhu, C Wu, E Baloglu, D Schmidt, R Ramesh, 
M Lobera, MS Sundrud, PY Tsai, Z Xiang, J 
Genes in Th17 differentiation
 433 © 1996-2016
Wang, Y Xu, X Lin, K Kretschmer, PB Rahl, 
RA Young, Z Zhong, DA Hafler, A Regev, 
S Ghosh, A Marson, VK Kuchroo: Small-
molecule RORgt antagonists inhibit T helper 
17 cell transcriptional network by divergent 
mechanisms. Immunity 40(4), 477-489 (2014)
DOI: 10.1016/j.immuni.2014.04.004
PMid:24745332, PMCid: PMC4066874
19. M Ganjalikhani Hakemi, K Ghaedi, V 
Homayouni, A Andalib, M Hosseini, A Rezaei: 
Positive and Negative Regulation of Th17 
Cell Differentiation: Evaluating The Impact of 
RORC2. Cell J 16(3), 343-352 (2014)
PMid:24611151, PMCid: PMC4204187
20. S Nakae, Y Iwakura, H Suto, SJ Galli: 
Phenotypic differences between Th1 and 
Th17 cells and negative regulation of Th1 
cell differentiation by IL-17. J Leuk Bio 81, 
1258-1268 (2007)
DOI: 10.1189/jlb.1006610 
PMid:17307864
21. G Huang, Y Wang, H Chi: Regulation of Th17 
cell differentiation by innate immune signals. 
Cell Mol Immunol 9(4), 287–295 (2012)
DOI: 10.1038/cmi.2012.10
PMid:22504954, PMCid: PMC3423893
22. T Korn, E Bettelli, M Oukka, VK Kuchroo: 
IL-17 and Th17 Cells. Anna Rev Immunol 27, 
485-517 (2009)
DOI: 10.1146/annurev.immunol.021908. 
132710
PMid:19132915
23. A Brüstle, S Heink, M Huber, C Rosenplänter, 
C Stadelmann, P Yu, E Arpaia, TW Mak, 
T Kamradt, M Loboff: The development 
of inflammatory T(H)-17 cells requires 
interferon-regulatory factor 4. Nat Immunol 8, 
958-966 (2007)
DOI: 10.1038/ni1500
PMid:17676043
24. Q Chen, W Yang, S Gupta, P Biswas, P Smith, 
G Bhagat, AB Pernis: IRF-4-binding protein 
inhibits interleukin-17 and interleukin-21 
production by controlling the activity of 
IRF-4 transcription factor. Immunity 29:(6), 
899-911 (2008)
DOI: 10.1016/j.immuni.2008.10.011
PMid:19062315 PMCid: PMC2633410
25. M Huber, A Brüstle, K Reinhard, A Guralnik, G 
Walter, A Mahiny, E von Löw, M Lohoff: IRF4 
is essential for IL-21-mediated induction, 
amplification, and stabilization of the Th17 
phenotype. Proc Natl Acad Sci USA 105, 
20846-20851 (2008)
DOI: 10.1073/pnas.0809077106 
PMid:19088203, PMCid: PMC2634912
26. Y Chung, SH Chang, GJ Martinez, XO Yang, 
R Nurieva, HS Kang, L Ma, SS Watowich, AM 
Jetten, Q Tian, C Dong: Critical regulation of 
early Th17 cell differentiation by interleukin-1 
signaling. Immunity 30, 576-587 (2009)
DOI: 10.1016/j.immuni.2009.02.007 
PMid:19362022,  PMCid: PMC2705871
27. DR Echlin, HJ Tae, N Mitin, EJ Taparowsky: 
B-ATF functions as a negative regulator 
of AP-1 mediated transcription and blocks 
cellular transformation by Ras and Fos. 
Oncogene 19, 1752- 1763 (2000)
DOI: 10.1038/sj.onc.1203491 
PMid:10777209
28. GJ Martinez, RI Nurieva, XO Yang, C Dong: 
Regulation and function of proinflammatory 
TH17 cells. Ann N Y Acad Sci 1143, 
188-211 (2008)
DOI: 10.1196/annals.1443.021
PMid:19076351
29. GJ Martinez, C Dong: BATF: bringing (in) 
another Th17-regulating factor. J Mol Cell Biol 
1, 66-68 (2009)
DOI: 10.1093/jmcb/mjp016
PMid:19726487
30. BU Schraml, K Hildner, W Ise, WL Lee, 
WA Smith, B Solomon, G Sahota, J Sim, R 
Mukasa, S Cemerski, RD Hatton, GD Stormo, 
CT Weaver, JH Russell, TL Murphy, KM 
Murphy: The AP-1 transcription factor Batf 
controls T(H)17 differentiation. Nature 460, 
405-409 (2009)
PMid:19578362    PMCid: PMC2716014
31. IM Djuretic, D Levanon, V Negreanu, Y 
Groner, A Rao, KM Ansel: Transcription 
factors T-bet and Runx3 cooperate to activate 
Ifng and silence Il4 in T helper type 1 cells. 
Nat immunol 8, 145-153 (2007)
DOI:  10.1038/ni1424 
PMid:17195845
32. T Egawa, RE Tillman, Y Naoe, I Taniuchi, DR 
Littman: The role of the Runx transcription 
factors in thymocyte differentiation and in 
homeostasis of naive T cells. J Exp Med 204, 
1945-1957 (2007)
DOI:  10.1084/jem.20070133  
Genes in Th17 differentiation
 434 © 1996-2016
PMid:17646406   PMCid: PMC2118679
33. A Collins, DR Littman, I Taniuchi: RUNX 
proteins in transcription factor networks 
that regulate T-cell lineage choice. Nat Rev 
Immunol 9, 106-115 (2009)
DOI:  10.1038/nri2489
PMid:19165227 PMCid: PMC4231139
34. Y Wang, J Godec, K Ben-Aissa, K Cui, K 
Zhao, AB Pucsek, YK Lee, CT Weaver, R 
Yagi, V Lazarevic: The transcription factors 
T-bet and Runx are required for the ontogeny 
of pathogenic interferon-g-producing T helper 
17 cells. Immunity 40(3), 355-366 (2014)
DOI:  10.1016/j.immuni.2014.01.002 
PMid:24530058 PMCid: PMC3965587
35. D Mucida, Y Park, G Kim, O Turovskaya, I 
Scott, M Kronenberg, H Cheroutre: Reciprocal 
TH17 and regulatory T cell differentiation 
mediated by retinoic acid. Science 317, 
256-260 (2007)
DOI:  10.1126/science.1145697 
PMid:17569825
36. M Veldhoen, K Hirota, AM Westendorf, J 
Buer, L Dumoutier, JC Renauld, B Stockinger: 
The aryl hydrocarbon receptor links TH17-
cell-mediated autoimmunity to environmental 
toxins. Nature 453, 106-109 (2008)
DOI:  10.1038/nature06881 
PMid:18362914
37. FJ Quintana, AS Basso, AH Iglesias, T 
Korn, MF Farez, E Bettelli, M Caccamo, M 
Oukka, HL Weiner: Control of Treg and TH17 
cell differentiation by the aryl hydrocarbon 
receptor. Nature 453, 65-71 (2008)
DOI:  10.1038/nature06880 
PMid:18362915
38. EV Dang, J Barbi, HY Yang, D Jinasena, H 
Yu, Y Zheng, Z Bordman, J Fu, Y Kim, HR 
Yen, W Luo, K Zeller, L Shimoda, SL Topalian, 
GL Semenza, CV Dang, DM Pardoll, F Pan: 
Control of T(H)17/T(reg) balance by hypoxia-
inducible factor 1. Cell 146, 772-784 (2011)
DOI:  10.1016/j.cell.2011.07.033 
PMid:21871655 PMCid: PMC3387678
39. L Zhou, JE Lopes, MMW Chong, II Ivanov, R 
Min, GD Victora, Y Shen, J Du, YP Rubtsov, 
AY Rudensky, SF Ziegler, DR Littman: TGF-b-
induced Foxp3 inhibits Th17 cell differentiation 
by antagonizing RORct function. Nature 453, 
236-241 (2008)
DOI:  10.1038/nature06878
PMid:18368049  PMCid: PMC2597437
40. SJ Szabo, ST Kim, GL Costa, X Zhang, CG 
Fathman, LH Glimcher: A novel transcription 
factor, T-bet, directs Th1 lineage commitment. 
Cell 100l, 655-669 (2000)
DOI: 10.1016/S0092-8674(00) 80702-3
41. V Lazarevic, X Chen, JH Shim, ES Hwang, 
EJang, AN Bolm, M Oukka, VK Kuchroo, 
LH Glimcher: T-bet represses T(H)17 
differentiation by preventing Runx1-mediated 
activation of the gene encoding RORgammat. 
Nat Immunol 12l, 96-104 (2011)
DOI:  10.1038/ni.1969
PMid:21151104  PMCid: PMC3077962
42. R Nurieva, XO Yang, G Martinez, Y Zhang, 
AD Panopoulos, L Ma, K Schluns, Q Tian, 
SS Watowich, AM Jetten, C Dong: Essential 
autocrine regulation by IL-21 in the generation 
of inflammatory T cells. Nature 448, 
480-483 (2007)
DOI:  10.1038/nature05969
PMid:17581589
43. XO Yang, AD Panopoulos, R Nurieva, SH 
Chang, D Wang, SS Watowich, C Dong: STAT3 
regulates cytokine-mediated generation of 
inflammatory helper T cells. J Biol Chem 282, 
9358-9363 (2007)
DOI:  10.1074/jbc.C600321200 
PMid:17277312
44. TJ Harris, JF Grosso, HR Yen, H Xin, M 
Kortylewski, E Albesiano, EL Hipkiss, D 
Getnet, MV Goldberg, CH Maris, F Housseau, 
H Yu, DM Pardoll, CG Drake: Cutting 
edge: An in vivo requirement for STAT3 
signaling in TH17 development and TH17-
dependent autoimmunity. J Immunol 179(7), 
4313-4317 (2007)
DOI:  10.4049/jimmunol.179.7.4313
PMid:17878325
45. L Durant, WT Watford, HL Ramos, A Laurence, 
G Vahedi, L Wei, H Takahashi, HW Sun, Y 
Kanno, F Powrie, JJ O’Shea: Diverse targets 
of the transcription factor STAT3 contribute 
to T cell pathogenicity and homeostasis. 
Immunity 32(5), 605-615 (2010)
DOI:  10.1016/j.immuni.2010.05.00
PMid:20493732 PMCid: PMC3148263
46. F Chalmin, G Mignot, M Bruchard, A 
Chevriaux, F Vegran, A Hichami, S Ladoire, 
V Derangere, J Vincent, D Masson, SC 
Robson, G Eberl, JR ́ Pallandre, C Borg, B 
Genes in Th17 differentiation
 435 © 1996-2016
Ryffel, L Apetoh, C Rebe, F Ghiringhelli: 
Stat3 and Gfi-1 Transcription Factors Control 
Th17 Cell Immunosuppressive Activity via the 
Regulation of Ectonucleotidase Expression. 
Immunity 36, 362-373 (2012)
DOI:  10.1016/j.immuni.2011.12.019
PMid:22406269
47. JH Yoon, K Sudo, M Kuroda, M Kato, IK Lee, 
JS Han, S Nakae, T Imamura, J Kim, JH Ju, DK 
Kim, K Matsuzaki, M Weinstein, I Matsumoto, 
T Sumida, M Mamura: Phosphorylation 
status determines the opposing functions of 
Smad2/Smad3 as STAT3 cofactors in TH17 
differentiation. Nat Commun 6, 7600 (2015)
DOI:  10.1038/ncomms8600
PMid:26194464  PMCid: PMC4518312
48. R Duhen, S Glatigny, CA Arbelaez, TC 
Blair, M Oukka, E Bettelli: Cutting edge: 
the pathogenicity of IFN-gamma-producing 
Th17 cells is independent of T-bet. J Immunol 
190(9), 4478-4482 (2013)
DOI:  10.4049/jimmunol.1203172 
PMid:23543757 PMCid: PMC3633668
49. WT Watford, BD Hissong, JH Bream, Y 
Kanno, L Muul, JJ O’Shea: Signaling by IL-12 
and IL-23 and the immunoregulatory roles of 
STAT4. Immunol Rev 202, 139-156 (2004)
DOI:  10.1111/j.0105-2896.2004.00211.x
PMid:15546391
50. Z Yao, Y Kanno, M Kerenyi, G Stephens, L 
Durant, WT Watford, A Laurence, GW Robinson, 
EM Shevach, E Moriggl, L Hennighausen, 
C Wu, JJ O’Shea: Nonredundant roles for 
Stat5a/b in directly regulating Foxp3. Blood 
109(10), 4368-4375 (2007)
DOI:  10.1182/blood-2006-11-055756
PMid:17227828  PMCid: PMC1885496
51. L Klotz, S Burgdorf, I Dani, K Saijo, J 
Flossdorf, S Hucke, J Alferink, N Nowak, M 
Beyer, G Mayer, B Langhans, T Klockgether, 
A Waisman, G Eberl, J Schultze, M Famulok, 
W Kolanus, C Glass, C Kurts, PA Knolle: The 
nuclear receptor PPAR gamma selectively 
inhibits Th17 differentiation in a T cell-intrinsic 
fashion and suppresses CNS autoimmunity. 
J Exp Med 206, 2079-2089 (2009)
DOI:  10.1084/jem.20082771 
DOI:  10.1084/jem.20082771120409c
PMid:19737866
52. B Li, JM Reynolds, RD Stout, DA Bernlohr, 
J Suttles: Regulation of Th17 differentiation 
by epidermal fatty acid-binding protein. 
J Immunol 182, 7625-7633 (2009)
DOI:  10.4049/jimmunol.0804192
PMid:19494286 PMCid: PMC2707838
Key Words: Th17, Th17 Differentiation, RORs, 
IRF4, BATF, RUNX1, FOXP3, STATs, Review
Send correspondence to: Ayten Nalbant, İzmir 
Institute of Technology, Department of Molecular 
Biology and Genetics, Molecular Immunology and 
Gene Regulation Laboratory, Urla, İzmir, 35430 
Turkey, Tel: 90 232 7507317, Fax: 90 232 7507303, 
E-mail: aytennalbant@iyte.edu.tr
